Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Rusch

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Leukemia|October 7, 2025
Clinical experience of using integrated whole genome and transcriptome sequencing as a framework for pediatric and adolescent acute myeloid leukemia diagnosis and risk assessmentRebecca K Voss, Victor B Pastor Loyola, Maria F Cardenas, et al.
Nature Communications|March 20, 2015
Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemiaXiaotu Ma, Michael Edmonson, Donald Yergeau, et al.
Cancer Discovery|September 17, 2014
Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutationsFranck Tirode, Didier Surdez, Xiaotu Ma, et al.
Nature|January 13, 2012
A novel retinoblastoma therapy from genomic and epigenetic analysesJinghui Zhang, Claudia A Benavente, Justina McEvoy, et al.
The New England Journal of Medicine|November 19, 2015
Germline Mutations in Predisposition Genes in Pediatric CancerJinghui Zhang, Michael F Walsh, Gang Wu, et al.
Cancer Discovery|February 23, 2020
Relapse-Fated Latent Diagnosis Subclones in Acute B Lineage Leukemia Are Drug Tolerant and Possess Distinct Metabolic ProgramsStephanie M Dobson, Laura García-Prat, Robert J Vanner, et al.
Nature Genetics|January 24, 2017
Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomesJasmijn D E de Rooij, Cristyn Branstetter, Jing Ma, et al.
Cancer Cell|August 28, 2018
Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic AnalysesElizabeth Stewart, Justina McEvoy, Hong Wang, et al.
Acta Neuropathologica|January 27, 2016
Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphologyIbrahim Qaddoumi, Wilda Orisme, Ji Wen, et al.
Cancer Cell|February 10, 2016
Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic LeukemiaIlaria Iacobucci, Yongjin Li, Kathryn G Roberts, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Leukemia|October 7, 2025
Clinical experience of using integrated whole genome and transcriptome sequencing as a framework for pediatric and adolescent acute myeloid leukemia diagnosis and risk assessmentRebecca K Voss, Victor B Pastor Loyola, Maria F Cardenas, et al.
Nature Communications|March 20, 2015
Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemiaXiaotu Ma, Michael Edmonson, Donald Yergeau, et al.
Cancer Discovery|September 17, 2014
Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutationsFranck Tirode, Didier Surdez, Xiaotu Ma, et al.
Nature|January 13, 2012
A novel retinoblastoma therapy from genomic and epigenetic analysesJinghui Zhang, Claudia A Benavente, Justina McEvoy, et al.
The New England Journal of Medicine|November 19, 2015
Germline Mutations in Predisposition Genes in Pediatric CancerJinghui Zhang, Michael F Walsh, Gang Wu, et al.
Cancer Discovery|February 23, 2020
Relapse-Fated Latent Diagnosis Subclones in Acute B Lineage Leukemia Are Drug Tolerant and Possess Distinct Metabolic ProgramsStephanie M Dobson, Laura García-Prat, Robert J Vanner, et al.
Nature Genetics|January 24, 2017
Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomesJasmijn D E de Rooij, Cristyn Branstetter, Jing Ma, et al.
Cancer Cell|August 28, 2018
Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic AnalysesElizabeth Stewart, Justina McEvoy, Hong Wang, et al.
Acta Neuropathologica|January 27, 2016
Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphologyIbrahim Qaddoumi, Wilda Orisme, Ji Wen, et al.
Cancer Cell|February 10, 2016
Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic LeukemiaIlaria Iacobucci, Yongjin Li, Kathryn G Roberts, et al.
Pageof 7